Forte Biosciences Inc — Cash Flow (NASDAQ:FBRX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -18.42 M-16.68 M-8.19 M-28.71 M-30.75 M-50.88 M -50.88 M Cash from investing activities 3.58 M3.58 M—47 K-35.99 M36.23 M 36.23 M Cash from financing activities 66.67 M-44 K7.24 M24.68 M51.86 M69.36 M 69.36 M Free cash flow -18.42 M-16.68 M-8.19 M-28.79 M-30.78 M-51 M -51 M

Nouvelles

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Forte Biosciences: Bull Run Could Continue Thanks To Near-Term Data Readouts

Forte Biosciences fixe le prix d’une offre d’actions de 150 millions de dollars à 26,27 dollars par action

Mouvements après clôture : Constellation Brands, Applied Digital, STAAR Surgical, New Era Energy & Digital

Forte Biosciences lance une offre publique d’actions

Guggenheim réitère sa recommandation sur Forte Biosciences avant les données

Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know

Micron, Insmed among market cap stock movers on Thursday

Evercore ISI initie la couverture de Forte Biosciences avec une recommandation Surperformance

Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating

Guggenheim initiates Forte Biosciences stock with Buy rating on autoimmune therapy potential

Forte Biosciences Announces Pricing of $75 Million Public Offering